Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 95%
filed 2026-07-15
Item 2.02
Winmark disclosed second quarter and six-month 2026 financial results, reporting net income of $10.4 million for Q2 and $19.6 million year-to-date, along with condensed financial statements including balance sheets, statements of operations, and cash flows.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-15
Item 8.01
The Board of Directors approved a quarterly cash dividend of $1.02 per share, payable on September 1, 2026 to shareholders of record on August 12, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-15
Item 1.01
Aspira Women's Health Inc. entered into a Subordinated Business Loan and Security Agreement with Agile Lending, LLC on July 6, 2026, creating a new direct financial obligation of $1,050,000 principal, maturing January 26, 2027, with $441,000 in interest charges.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
The filing discloses the appointment of Brent MacDonald to Socket Mobile's Board of Directors effective July 13, 2026. MacDonald, who previously served on the Board from 2016 to 2023, has been reappointed as an independent director. This is a clear executive appointment event under Item 5.02, and the Board's determination of his independence status and standard director compensation arrangements are disclosed. The appointment is material as it affects the composition and governance of the company's board.
View raw filing on EDGAR →
6-K
Operational Other
confidence 72%
filed 2026-07-15
EX-99.1
This exhibit discloses preliminary key performance indicators (KPIs) for Q2 2026 across Auna's healthcare operations in Mexico, Peru, and Colombia—including emergency treatments, surgeries, hospitalization days, capacity utilization, and oncology sessions. While the company explicitly states these are "preliminary in nature" and subject to revision, the KPIs provide material operational visibility into the company's healthcare delivery performance across its three geographic segments and would inform a reasonable investor's assessment of operational trends and capacity management.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 94%
filed 2026-07-15
Item 1.01
Martin Marietta Materials entered into a $1.5 billion three-year senior unsecured term loan facility with JPMorgan Chase Bank as administrative agent on July 15, 2026, with proceeds designated to fund a portion of cash consideration for the previously announced Lhoist North America acquisition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-15
Item 7.01
The filing announces Group 1 Automotive's plan to release financial results for the second quarter ended June 30, 2026, on July 30, 2026, with a conference call to follow. The press release (Exhibit 99.1) explicitly states the company "will release financial results for the second quarter ended June 30, 2026" and describes the earnings call details. This is a standard earnings release announcement, material to investors as quarterly financial results directly affect the total mix of information available about the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-15
Item 2.02
AITX disclosed Q1 FY2027 financial results for the period ended May 31, 2026, reporting total revenue of $1.83 million, an operating loss of $2.71 million, and improved cash use. The earnings announcement was furnished via press release (Exhibit 99.1) and includes detailed financial metrics and management commentary on operational performance and outlook.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-15
EX-99.6
Platinum Group Metals Ltd. announced third quarter 2026 financial results for the nine months ended May 31, 2026, disclosing a net loss of $2.88 million, along with operational updates on the Waterberg Project and company outlook.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-15
EX-99.1
Elemental Royalty has entered into a strategic US$25 million investment package with Quilla Resources to acquire an additional 1.0% NSR royalty over the Pampa Negra and Candelaria concessions at the Chapi Copper Project, plus approximately 9% equity stake in Quilla. This is a material acquisition of royalty rights and equity investment that expands the company's exposure to a producing asset and represents a significant capital deployment, meeting the definition of ma_activity under Item 1.01 (material acquisition).
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-15
EX-99.1
This is a Q2 2026 production results and financial highlights announcement disclosing record gold sales of 14,610 oz, revenues of ~$63 million, and cash/securities balance of $112 million. The exhibit presents quarterly operational metrics, financial performance, and a corporate update in the format of a press release announcing periodic quarterly results—the hallmark of an earnings_release event.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-15
Item 8.01
The filing discloses a declaration of a quarterly cash dividend of $0.10 per share payable on August 19, 2026, to shareholders of record on July 29, 2026. This is a routine but material capital allocation decision that affects shareholder value and is commonly disclosed under Item 8.01 (Other Events) as a dividend distribution event.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-15
EX-99.1
This exhibit is the "Second Amended and Restated 2019 Share Incentive Plan" for NetEase, Inc., which establishes the framework for granting Restricted Share Units and Options to Eligible Participants (Employees, Directors, and Consultants). The document sets forth the purposes, definitions, and governance structure for equity compensation awards. As a material amendment to the company's equity incentive plan affecting director and officer compensation arrangements, this constitutes an executive compensation disclosure under the taxonomy.
View raw filing on EDGAR →
6-K
Material Litigation
confidence 92%
filed 2026-07-15
The 6-K announces the final award in an arbitration proceeding against Juventas Co., Ltd. before the Hong Kong International Arbitration Centre. The tribunal rejected all of Juventas's breach allegations, determined Juventas wrongfully terminated the parties' agreements regarding CNCT-19 commercialization, and awarded CASI "well over RMB 100 million" in wasted costs, interest, tribunal costs, and legal fees. This is a material litigation settlement/award that would affect a reasonable investor's assessment of the company's financial position and legal standing.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-15
EX-99.1
This exhibit is a preliminary operational KPI announcement for Q2 2026, disclosing platform metrics (transactions, GBV, carrier/buyer growth) that exceeded management expectations. While the company explicitly states "The Company Plans to Report Earnings on August 17, 2026," this is not itself an earnings release but rather an advance disclosure of operational performance indicators. The metrics—458k transactions (up 15% YoY), $422M GBV (up 33% YoY), and 75 active carriers—are material to investors assessing platform scale and momentum, particularly given the company's strategic focus on scaling solutions and the recovery from Middle East geopolitical disruption. This is best classified as operational_other because it discloses material operational performance and strategic progress without being a formal earnings release or periodic financial report.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-15
EX-99.2
Glass House Brands Inc. announced an updated at-the-market (ATM) distribution program permitting the sale of up to US$100 million of equity shares in the United States and Canada under an amended and restated equity distribution agreement with ATB Capital Markets and Wilson-Davis & Co. as agents.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-15
This 8-K discloses a business update via Item 7.01 (Regulation FD) with a press release covering multiple operational and strategic developments: debottlenecking of the North Dakota facility to increase production capacity, expansion project targeting 150 million gallons per year, progress on Project Northstar SAF facility (FEL-3 engineering with ~$600M capex), monetization of Section 45Z tax credits (~$70M in 2026), and notably, consideration of exiting the Lake Preston SAF project with expected significant non-cash write-downs. While the filing touches on financial metrics (Adjusted EBITDA growth, tax credit monetization) and operational improvements, the core disclosure centers on strategic business progress and capital allocation decisions rather than a discrete financial event, M&A activity, or governance matter. The Lake Preston wind-down with anticipated write-downs approaches material_impairment territory, but the primary focus is operational strategy rather than the impairment itself.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-07-15
Item 8.01
NRG Energy disclosed the results of PJM's capacity auction for the 2028-2029 delivery year, showing the company cleared 6,839 MW at $325 per MW-day. This is an operational/commercial milestone reflecting the company's capacity procurement success in a key regional market, but does not fit the specific categories of earnings release, M&A, debt issuance, or other named event types. The disclosure is material as it affects investor assessment of the company's revenue visibility and operational positioning in the PJM market.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-15
EX-99.1
Canaan received written notification from Nasdaq granting an additional 180-day compliance period (until January 11, 2027) to regain compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The Company previously received an initial notification on January 14, 2026, and has now exhausted its first compliance period. This disclosure directly addresses continued listing status and the risk of delisting if the Company fails to meet the minimum bid price threshold during the second compliance period.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-15
Item 7.01
Republic Bancorp declared a cash dividend of $0.495 per share on Class A Common Stock and $0.45 per share on Class B Common Stock, payable October 16, 2026. This is a straightforward dividend declaration disclosed via news release under Item 7.01 (Regulation FD Disclosure), which is material to shareholders as it represents a distribution of capital and signals the company's financial health and capital allocation policy.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-15
Item 8.01
The filing discloses a declaration of a quarterly cash dividend of $0.29 per share on common stock, payable August 7, 2026. This is a routine but material capital allocation decision that affects shareholder value and is typically disclosed in Item 8.01 (Other Events) via press release. The specific dividend amount, record date, and payment date are all clearly stated.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-15
Item 1.01
Prestige Consumer Healthcare issued $400 million aggregate principal amount of 6.250% senior notes due 2034 pursuant to an Indenture dated July 15, 2026, creating a new direct financial obligation.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-15
Item 5.02
Sam Martin, Senior Vice President and Chief Financial Officer, notified the Company of his plans to retire effective March 31, 2027. The principal disclosed action is the departure of a named executive officer (CFO) from the Company, with a clear effective date and transition plan. This is a material event affecting investor assessment of the registrant's leadership and financial management continuity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
The filing discloses the appointment of James H. Bradshaw as a member of RLI's Board of Directors, effective July 15, 2026, with assignment to the Audit and Finance & Risk Committees. The principal disclosed action is a person taking a role (board appointment), making this an exec_appointment event. The appointment of a director with significant industry experience (40+ years in insurance leadership) to key board committees is material to investors' assessment of governance and strategic direction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-15
Item 1.01
TriCo Bancshares entered into an Agreement and Plan of Reorganization and Merger with First Hawaiian, Inc. on July 12, 2026, whereby TriCo shareholders will receive 2.095 shares of FHI common stock per TriCo share in a multi-step merger transaction, subject to customary closing conditions including regulatory approvals and shareholder votes, with an $80 million termination fee provision.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-15
Item 5.02
TriCo Bancshares approved a special one-time transaction bonus of $2,500,000 to Richard P. Smith, TriCo's Chairman, President and CEO, contingent on continued employment through merger closing.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-15
Item 1.01
First Hawaiian, Inc. entered into an Agreement and Plan of Reorganization and Merger with TriCo Bancshares on July 12, 2026, providing for a two-step merger structure followed by a bank merger, with TriCo shareholders receiving 2.095 shares of FHI Common Stock per share held. This is a material acquisition/change of control transaction requiring stockholder approvals and regulatory clearances from the Federal Reserve, FDIC, and state banking authorities, clearly falling under Item 1.01 M&A activity.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-15
Item 8.01
Deere & Company's subsidiary, Deere Funding Canada Corporation, issued $300 million in 4.850% senior unsecured notes due July 15, 2031, fully guaranteed by the parent company. This is a material creation of a direct financial obligation disclosed under Item 8.01, representing a significant debt issuance that would affect a reasonable investor's assessment of the company's capital structure and financial position.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-15
Item 1.01
Yorkville Acquisition Corp. issued an Amended and Restated Working Capital Note in the aggregate principal amount of $500,000 to its Sponsor on May 4, 2026. The note is convertible and unsecured, creating a material direct financial obligation that affects the Company's capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-15
Item 3.02
The Amended and Restated Working Capital Note is convertible into up to 50,000 New Units, each comprising Class A ordinary shares and warrant fractions, issued as an unregistered private placement relying on Section 4(a)(2) of the Securities Act. This conversion feature creates a material dilutive issuance to existing shareholders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-15
Item 2.02
Matson issued a press release on July 15, 2026 announcing preliminary earnings for the quarter ended June 30, 2026, disclosing expected consolidated operating income of $153.0–$160.0 million, net income of $124.8–$130.3 million, and diluted EPS of $4.12–$4.30. The filing is made under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1 and an investor presentation as Exhibit 99.2, which is the standard format for earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-07-15
Item 2.02
Prudential Financial disclosed Q2 2026 financial results, including preliminary financial information such as PGIM assets under management of $1.49 trillion and segment-level adjusted operating income impacts from actuarial assumption updates ranging from -$90M to +$80M across segments.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-07-15
EX-99.1
This exhibit is an invitation to a webcast and conference call announcing the Company's plan to release Q2 2026 financial results on August 11, 2026, with a call scheduled for August 12, 2026. While the actual earnings figures are not disclosed in this document, the announcement of the upcoming earnings release and the scheduled call to discuss Q2 2026 results (April 1 to June 30) constitutes disclosure of a material earnings event. The confidence is moderate (0.75) because this is technically an invitation/notice rather than the earnings release itself, but it is the Company's formal announcement of its earnings disclosure date and is material to investors.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-07-15
Item 8.01
The filing discloses a remarketing of $217.4 million in Class A-5 Reset Rate Notes by SLM Student Loan Trust 2005-5, with Navient Solutions as administrator and Goldman Sachs as remarketing agent. The preliminary remarketing memorandum was furnished on July 15, 2026, for distribution to qualified institutional buyers ahead of the July 27, 2026 reset date. This is a material capital markets transaction involving the refinancing/remarketing of outstanding asset-backed securities, which would affect investor assessment of the trust's financing activities and note terms, but does not fit neatly into debt_issuance (which typically applies to new debt creation) or other specific categories—it is an operational/capital markets event involving the restructuring of existing obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-07-15
Item 8.01
Jefferies Financial Group consummated a public offering of €850 million aggregate principal amount of 4.500% Senior Notes due 2033 on July 15, 2026. This is a creation of a new direct financial obligation through debt issuance, with net proceeds of approximately €843.8 million to be used for general corporate purposes. The disclosure clearly describes the completion of a material debt offering under Item 8.01.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-15
Item 8.01
The filing discloses the furnishing of a preliminary remarketing memorandum for the remarketing of approximately $123.7 million in Class A-5 Reset Rate Notes by SLM Student Loan Trust 2005-7. While technically a "remarketing" of existing notes rather than a new issuance, this represents a material refinancing event involving the reset of interest rate terms and the solicitation of new investors to purchase the outstanding notes. The event involves the creation or modification of direct financial obligations and would materially affect investor assessment of the trust's capital structure and financing terms.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-07-15
Item 8.01
The filing discloses the furnishing of a preliminary remarketing memorandum for the reset and remarketing of approximately $165.7 million in Class A-6B and Class A-6C student loan-backed notes originally issued in 2006. This is a material capital markets event involving the refinancing/reset of existing debt obligations, but it does not fit neatly into the debt_issuance category (which applies to creation of new obligations) nor any other specific category. The remarketing is an operational/capital management activity that would affect investor assessment of the trust's liquidity and refinancing risk, making it material and best classified as operational_other.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-15
EX-99.1
Performance Shipping extended its time charter contract for the M/T Blue Moon tanker vessel with American Eagle Tankers for 24 months at an average rate of US$40,500 per day, generating approximately US$29 million in gross revenue and increasing contracted revenue backlog to over US$530 million.
View raw filing on EDGAR →
6-K
Financial Other
confidence 85%
filed 2026-07-15
EX-99.2
Performance Shipping completed the sale and delivery of the M/T P. Sophia tanker vessel for US$35.65 million, representing a 30% gain over the 2022 acquisition price of US$27.6 million and strengthening the company's liquidity position.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-15
Item 8.01
Atlantic American Corporation disclosed that Nasdaq has notified it of non-compliance with Listing Rule 5250(c)(1) due to delayed filing of its Form 10-K and Form 10-Q. The company has been granted an extension until October 12, 2026 to regain compliance, with explicit warning that failure to do so will result in delisting notification from Nasdaq. This is a classic delisting-risk disclosure under Item 3.01 (though filed under Item 8.01), materially threatening the continued listing of the company's common stock.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-15
Item 5.07
This Item 5.07 disclosure reports the results of an extraordinary general meeting of shareholders held on July 15, 2026, where PCSC shareholders voted on and approved multiple proposals including the Business Combination Proposal, Domestication Proposal, Governing Documents Proposal, Nasdaq Proposal, and equity plan proposals. The filing provides detailed voting tallies for each proposal, quorum information (75.65% of voting power present), and confirms approval of all substantive matters. This is a classic shareholder vote results disclosure material to investors evaluating the company's business combination transaction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-15
Item 2.02
Elevance Health issued a press release on July 15, 2026, reporting second quarter 2026 financial results, including operating revenue of $49.8 billion, diluted EPS of $6.71, and adjusted diluted EPS of $7.45. The company also raised full-year 2026 guidance for diluted EPS to at least $20.10 and adjusted diluted EPS to at least $27.00. This is a standard quarterly earnings release with detailed financial statements, segment performance, and forward guidance—a material disclosure affecting investor assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-15
EX-99.1
This press release announces positive metallurgical test results validating the Kilbourne Graphite Project's concentrator flowsheet and downstream processing chain. The disclosure reports achievement of battery-grade purity (≥99.90% Fixed Carbon), concentrator performance exceeding PEA design assumptions (95.9% concentrate grade vs. 95% target; 91.4% recovery vs. 90% target), and industry-leading spherical graphite yields (66% vs. ~50% industry average). These are material operational and technical milestones de-risking the Feasibility Study and supporting the company's plan to build the first fully integrated U.S. graphite supply chain in over 70 years. The event is clearly operational/strategic (project development progress) rather than a discrete financial event, M&A activity, or governance matter, and does not fit the earnings_release category (which reports financial results, not technical project validation).
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-07-15
Legend Biotech announced preliminary net trade sales of approximately $657 million for CARVYKTI® during the quarter ended June 30, 2026. This is a discrete disclosure of quarterly financial results for a key product, announced on July 15, 2026, and constitutes an earnings release. The sales figure is material to investors assessing the company's commercial performance and revenue trajectory.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-15
EX-99.1
Rubico announced its decision to divest its newbuilding megayacht and exit the megayacht sector, with estimated gross proceeds of €30–€35 million ($34.2–$40 million) and elimination of a €26.5 million capital commitment. This is a material disposition of an asset and a strategic exit from a business line, fitting the definition of ma_activity (Items 1.02, 2.01). The company explicitly states the divestment would release capital for redeployment toward its core tanker business, representing a material change in capital allocation and asset composition.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-15
Item 2.03
First Mid Bancshares executed a Promissory Note for $19.7 million with a fixed interest rate of 6.125% and repayment terms extending to September 2029, creating a new direct financial obligation material to the company's capital structure.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-15
EX-99.1
Rubico has entered into a share purchase agreement to acquire 100% of the shares of a special purpose vehicle (SPV) that owns a shipbuilding contract for a 47,499 dwt MR tanker newbuilding from Guangzhou Shipyard. The acquisition price is approximately $6.25 million with expected closing by September 30, 2026. This constitutes a material acquisition under Item 1.01 of Form 8-K (or equivalent 6-K disclosure), expanding the company's fleet and increasing its potential gross revenue backlog to approximately $305 million, which would materially affect a reasonable investor's assessment of the registrant's future cash flows and asset base.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-15
EX-99.1
TOP Ships announced the sale of 100% of the shares of a special purpose vehicle (SPV) holding a shipbuilding contract for a 47,499 dwt tanker newbuilding to Rubico Inc for approximately $6.25 million, expected to close by September 30, 2026. This constitutes a material disposition of an asset (the SPV and its shipbuilding contract), approved by an independent special committee with a fairness opinion, and would affect a reasonable investor's assessment of the company's fleet composition and capital deployment strategy.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-07-15
EX-99.1
The exhibit discloses the appointment of Dr. Jeff Millard as Executive Vice President, Technical Operations effective July 13, 2026, and the elevation of Dr. Alex Therien to Executive Vice President, Research & Development. While the filing also mentions Amanda Malone's departure as Chief Scientific and Operating Officer, the primary announced action is the appointment of new executive leadership to support the company's clinical and commercial development. The material change report emphasizes these leadership updates as part of the company's evolution and operational restructuring.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-07-15
EX-99.1
This is Amending Agreement No. 3 to Stantec's credit agreement dated June 18, 2026, which modifies the terms of an existing direct financial obligation. The amendment extends maturity dates (Revolving Credit from June 2030 to June 2031, Term Tranche B from June 2027 to June 2029, Term Tranche C from June 2029 to June 2031), adjusts financial covenants (Leverage Ratio from 3.50 to 3.50/4.00, Interest Coverage from 3.00 to 2.75), and modifies interest rate mechanics. While this is technically an amendment rather than a new issuance, it constitutes a material modification of existing debt obligations that would affect investor assessment of the company's capital structure and covenant flexibility.
View raw filing on EDGAR →